You are here

  • Home
  • Archive
  • Volume 25, Issue 8
  • Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival

Article info

Article menu
Download PDFPDF
Cervical Cancer
Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival

Authors

  • Alessandro Buda Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano–Bicocca, Monza;“Mario Negri” Gynecology Oncology (MaNGO) Group, Milan; PubMed articlesGoogle scholar articles
  • Andrea Alberto Lissoni Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano–Bicocca, Monza;“Mario Negri” Gynecology Oncology (MaNGO) Group, Milan; PubMed articlesGoogle scholar articles
  • Irene Floriani “Mario Negri” Gynecology Oncology (MaNGO) Group, Milan;Laboratory of Clinical Research, Department of Oncology, IRCCS–Istituto di Ricerche Farmacologiche“Mario Negri,” Milan; and PubMed articlesGoogle scholar articles
  • Elena Biagioli “Mario Negri” Gynecology Oncology (MaNGO) Group, Milan;Laboratory of Clinical Research, Department of Oncology, IRCCS–Istituto di Ricerche Farmacologiche“Mario Negri,” Milan; and PubMed articlesGoogle scholar articles
  • Chiara Gerardi “Mario Negri” Gynecology Oncology (MaNGO) Group, Milan;Laboratory of Clinical Research, Department of Oncology, IRCCS–Istituto di Ricerche Farmacologiche“Mario Negri,” Milan; and PubMed articlesGoogle scholar articles
  • Cristina Bonazzi Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano–Bicocca, Monza;“Mario Negri” Gynecology Oncology (MaNGO) Group, Milan; PubMed articlesGoogle scholar articles
  • Stefania Chiari Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano–Bicocca, Monza;“Mario Negri” Gynecology Oncology (MaNGO) Group, Milan; PubMed articlesGoogle scholar articles
  • Luca Locatelli University of Milano–Bicocca, Monza, Italy. PubMed articlesGoogle scholar articles
  • Tiziana Dell’Anna Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano–Bicocca, Monza;“Mario Negri” Gynecology Oncology (MaNGO) Group, Milan; PubMed articlesGoogle scholar articles
  • Mauro Signorelli Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano–Bicocca, Monza;“Mario Negri” Gynecology Oncology (MaNGO) Group, Milan; PubMed articlesGoogle scholar articles
  • Costantino Mangioni Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano–Bicocca, Monza;“Mario Negri” Gynecology Oncology (MaNGO) Group, Milan; PubMed articlesGoogle scholar articles
  • Rodolfo Milani Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano–Bicocca, Monza;“Mario Negri” Gynecology Oncology (MaNGO) Group, Milan; PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Alessandro Buda, MD, Gynecologic Oncology Surgical Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano–Bicocca, Monza, Italy. E-mail: alebuda1972@gmail.com.

Citation

Buda A, Lissoni AA, Floriani I, et al
Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival
International Journal of Gynecologic Cancer 2015;25:1468-1475.

Publication history

  • Received February 23, 2015
  • First published October 1, 2015.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2015 by IGCS and ESGO